The interdependence of targets for continuous glucose monitoring outcomes in type 1 diabetes with automated insulin delivery
Diabetes, Obesity and Metabolism · 2024-12 · 26 (12) · 5836-5844
DOI: 10.1111/dom.15955 ↗At a glance
Journal article in Diabetes, Obesity and Metabolism, published online on 2024-09-26. Written by Javier Castañeda and 5 co-authors. Institution: Medtronic International Trading Sàrl, Tolochenaz, Switzerland. Major MEDLINE topics: Diabetes Mellitus, Type 1, Insulin Infusion Systems, Insulin, Blood Glucose. Cited 7 times so far (Crossref); 22 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Medtronic Europe.
Topics: Diabetes mellitus
Abstract (original language)
Aim
The aim was to determine the interdependence of targets for glucose management indicator (GMI), time within the ranges of 70–180 mg/dL (TIR) and 70–140 mg/dL (time in tight glucose range [TITR]), time above 180 mg/dL (TA180) and 250 mg/dL (TA250) and time below 70 mg/dL (TB70) and 54 mg/dL (TB54) and its implications for setting targets in automated insulin delivery (AID). Materials and Methods Real‐world data from individuals with type 1 diabetes using the 780G system were used to calculate the receiver operating characteristic curves and establish interdependent targets for time in ranges based on several GMI benchmarks. Correlation, regression and principal component analysis were used to determine their association and dimensionality.
Results
In individuals aged >15 years ( n = 41 692), a GMI 81%, >58%, 81% of the variability in the remaining continuous glucose monitoring (CGM) metrics, providing accurate predictions. Individuals aged ≤15 years ( n = 14 459) showed similar results.
Conclusion
We developed a methodology to establish interdependent CGM targets for therapies with CGM data outputs. In AID with the 780G system, a GMI
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Medtronic International Trading Sàrl, Tolochenaz, Switzerland.
- Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands.
- CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
- Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.
- Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre, Maastricht, The Netherlands.
ORCID profiles: Javier Castañeda, Bastiaan E de Galan, Sander M J van Kuijk, Tim van den Heuvel, Ohad Cohen
Funding
- Medtronic Europe
Cite
APA
Castañeda, J., de Galan, B. E., van Kuijk, S. M. J., Arrieta, A., van den Heuvel, T., & Cohen, O. (2024). The interdependence of targets for continuous glucose monitoring outcomes in type 1 diabetes with automated insulin delivery. Diabetes, Obesity and Metabolism, 26(12), 5836-5844. https://doi.org/10.1111/dom.15955
Vancouver
Castañeda J, de Galan BE, van Kuijk SMJ, Arrieta A, van den Heuvel T, Cohen O. The interdependence of targets for continuous glucose monitoring outcomes in type 1 diabetes with automated insulin delivery. Diabetes, Obesity and Metabolism. 2024;26(12):5836-5844. doi:10.1111/dom.15955
BibTeX
@article{Castaeda2024,
author = {Castañeda, Javier and de Galan, Bastiaan E and van Kuijk, Sander M J and Arrieta, Arcelia and van den Heuvel, Tim and Cohen, Ohad},
title = {The interdependence of targets for continuous glucose monitoring outcomes in type 1 diabetes with automated insulin delivery},
journal = {Diabetes, Obesity and Metabolism},
year = {2024},
volume = {26},
number = {12},
pages = {5836--5844},
doi = {10.1111/dom.15955}
}
EUVIMED